Načítá se...
Selective GPR55 antagonism reduces chemoresistance in cancer cells
G protein-coupled receptor 55 (GPR55) possesses pro-oncogenic activity and its function can be competitively inhibited with (R,R’)-4’-methoxy-1-naphthylfenoterol (MNF) through poorly defined signaling pathways. Here, the anti-tumorigenic effect of MNF was investigated in the human pancreatic cancer...
Uloženo v:
| Vydáno v: | Pharmacol Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5026616/ https://ncbi.nlm.nih.gov/pubmed/27423937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.07.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|